Protagonist Therapeutics ... (PTGX)

NASDAQ: PTGX · Real-Time Price · USD

45.16

-0.66 (-1.44%)

At close: May 01, 2025, 3:59 PM

44.63

-1.17%

Pre-market: May 02, 2025, 07:05 AM EDT

Protagonist Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	275.19M	-78.95M	-127.39M	-125.55M	-66.15M	-77.19M	-38.92M	-36.96M	-37.18M
Depreciation & Amortization	2.9M	3.31M	3.37M	2.77M	2.56M	2.5M	527K	406K	317K
Stock-Based Compensation	37.55M	29.29M	24.2M	16.39M	7.9M	8.35M	6.92M	4.24M	2.13M
Other Working Capital	n/a	-16.58M	-9.81M	-1.92M	-19.32M	29.14M	-23.53M	31.75M	3K
Other Non-Cash Items	-131.49M	-4.38M	-549K	1.83M	781K	-557K	206K	625K	4.72M
Deferred Income Tax	n/a	n/a	n/a	n/a	1.44M	-775K	-658K	n/a	151K
Change in Working Capital	n/a	-19.51M	-7.77M	-3.31M	-19.02M	26.14M	-18.02M	35.56M	-112K
Operating Cash Flow	184.15M	-70.24M	-108.14M	-107.86M	-72.48M	-41.53M	-49.95M	3.87M	-29.97M
Capital Expenditures	-1.35M	-609K	-795K	-1.1M	-471K	-967K	-486K	-666K	-379K
Cash Acquisitions	n/a	n/a	-91.47M	14.76M	90.49M	52.74M	n/a	n/a	32K
Purchase of Investments	-621.7M	-191.04M	-214.87M	-286.59M	-280.03M	-166.94M	-71.06M	-39.55M	-73.17M
Sales Maturities Of Investments	323.57M	152.4M	307.14M	271.83M	189.53M	114.19M	73.76M	56.03M	14.19M
Other Investing Acitivies	n/a	n/a	91.47M	-14.76M	-90.49M	-52.74M	2.7M	16.49M	32K
Investing Cash Flow	-299.48M	-39.26M	91.47M	-15.86M	-90.97M	-53.71M	2.21M	15.82M	-59.33M
Debt Repayment	n/a	n/a	n/a	n/a	-10.52M	9.77M	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	25.85M	38.38M	4.29M	6.09M	2.79M	1.78M	934K	1.01M	151K
Financial Cash Flow	25.85M	170.48M	18.84M	129.92M	247.63M	46.04M	24.11M	65.55M	106.31M
Net Cash Flow	-89.48M	60.98M	2.08M	6.07M	84.35M	-49.23M	-23.8M	85.39M	17.03M
Free Cash Flow	182.8M	-70.84M	-108.93M	-108.97M	-72.95M	-42.49M	-50.43M	3.21M	-30.35M